Pellicer-Chover Hilario, Cervera-Ballester Juan, Sanchis-Bielsa José M, Peñarrocha-Diago María A, Peñarrocha-Diago Miguel, García-Mira Berta
Student of the Master's Degree in Surgery and Implant Dentistry, Faculty of Medicine and Dentistry, University of Valencia, Spain.
Associate Lecturer in Oral Surgery, Faculty of Medicine and Dentistry, Adjunct Doctor at Valencia University General Hospital Dental Service, Spain.
J Clin Exp Dent. 2013 Apr 1;5(2):e66-71. doi: 10.4317/jced.50869.
The purpose of this study was to compare the clinical efficacy of articaine at 4% (epinephrine 1:100,000) with bupivacaine at 0.5% (epinephrine 1:200,000) for surgical extraction of impacted mandibular third molars.
This was a randomized, double blind, split-mouth, clinical trial. Thirty-six patients took part and underwent extraction of 72 lower third molars. The variables studied were: anesthetic latency time, intra-operative bleeding, anesthetic quality, hemodynamic changes during the surgical intervention, anesthetic duration in the soft tissues, post-operative analgesia and post-operative pain at 2, 6, 12 and 24 hours using a visual analogue scale, as well as any need for additional rescue medication.
Latency time was 2.0 minutes for articaine and 3.1 minutes for bupivacaine, with statistically significant difference (p<0.05). Bleeding was greater when bupivacaine was used (p<0.05) and anesthetic quality was greater with articaine (p<0.05). The duration of soft tissue anesthesia was longer with bupivacaine (p<0.05). Differences in post-operative analgesia, haemodynamic changes, post-operative pain and the quantity of rescue medication consumed were not statistically significant (p>0.05).
Articaine showed greater clinical efficacy than bupivacaine, reducing latency time, bleeding, anesthetic duration in the soft tissues and achieving higher anesthetic quality, requiring less reinforcement during surgery than bupivacaine. Key words:Articaine, bupivacaine, anesthetic efficacy, impacted mandibular third molar.
本研究旨在比较4%阿替卡因(肾上腺素1:100,000)与0.5%布比卡因(肾上腺素1:200,000)用于下颌阻生第三磨牙手术拔除的临床疗效。
这是一项随机、双盲、双侧对照的临床试验。36例患者参与,拔除72颗下颌第三磨牙。研究变量包括:麻醉潜伏期、术中出血、麻醉质量、手术干预期间的血流动力学变化、软组织麻醉持续时间、术后镇痛以及术后2、6、12和24小时使用视觉模拟评分法评估的术后疼痛,以及是否需要额外的急救药物。
阿替卡因的潜伏期为2.0分钟,布比卡因的潜伏期为3.1分钟,差异有统计学意义(p<0.05)。使用布比卡因时出血更多(p<0.05),而阿替卡因的麻醉质量更高(p<0.05)。布比卡因的软组织麻醉持续时间更长(p<0.05)。术后镇痛、血流动力学变化、术后疼痛和急救药物消耗量的差异无统计学意义(p>0.05)。
与布比卡因相比,阿替卡因具有更高的临床疗效,可缩短潜伏期、减少出血、缩短软组织麻醉持续时间并实现更高的麻醉质量,手术期间所需的强化麻醉比布比卡因少。关键词:阿替卡因、布比卡因、麻醉效果、下颌阻生第三磨牙